Lonnie Shea

About

Lonnie Shea is the Steven A. Goldstein Collegiate Professor at the University of Michigan, USA. His research primarily focuses on the development of engineered nanoparticles for immunotherapy and cancer treatment, as well as their applications in diabetes and neuropathic pain management. Recent publications include work on anti-TNF-α antisense-oligonucleotide-conjugated nanoparticles and studies on the metastatic potential of breast cancer through novel engineered niches.